2014
DOI: 10.1016/j.pharmthera.2014.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Methamphetamine-induced toxicity: An updated review on issues related to hyperthermia

Abstract: Reports of methamphetamine-related emergency room visits suggest that elevated body temperature is a universal presenting symptom, with lethal overdoses generally associated with extreme hyperthermia. This review summarizes the available information on methamphetamine toxicity as it pertains to elevations in body temperature. First, a brief overview of thermoregulatory mechanisms is presented. Next, central and peripheral targets that have been considered for potential involvement in methamphetamine hypertherm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
46
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(49 citation statements)
references
References 136 publications
(198 reference statements)
1
46
0
Order By: Relevance
“…Interestingly, a number of neuroprotective agents tested against METH toxicity were shown to lack significant effects on METH-induced hyperthermia (reviewed in Matsumoto et al, 2014). For example, that is the case for minocycline (Zhang et al, 2006), memantine (a NMDA antagonist) (Chipana et al 2008) or calcitriol (a vitamin D metabolite) (Cass et al, 2006) that proved to have neuroprotective effects in animals treated with METH without affecting METH-induced hyperthermia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, a number of neuroprotective agents tested against METH toxicity were shown to lack significant effects on METH-induced hyperthermia (reviewed in Matsumoto et al, 2014). For example, that is the case for minocycline (Zhang et al, 2006), memantine (a NMDA antagonist) (Chipana et al 2008) or calcitriol (a vitamin D metabolite) (Cass et al, 2006) that proved to have neuroprotective effects in animals treated with METH without affecting METH-induced hyperthermia.…”
Section: Discussionmentioning
confidence: 99%
“…METH use can be lethal due to hyperthermia (Schep et al, 2010). In clinical emergency settings, elevations in body temperature are a common presenting symptom with few treatment options (Matsumoto et al, 2014). Additionally, METH addicts show several signs of neuropathology that include biochemical and structural abnormalities (Cadet et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…While amphetamines are primarily associated with hyperthermia (Bowyer & Hanig, 2014;Matsumoto et al , 2014), acute decreases in body temperature are observed when they are administered at normothermic and lower ambient temperatures (Bowyer et al , 2001;Myles et al , 2008;Shortall et al , 2013) or at lower doses (Harkness et al , 2015), and particularly when animals are singly housed (Fantegrossi et al , 2008;Docherty & Green, 2010). Although MA-induced neurotoxicity is exacerbated by hyperthermia, (Bowyer et al , 1994;Miller & O’Callaghan, 2003;Sharma et al , 2015), neurotoxicity can still occur in its absence under the above conditions or when pharmacologically blocked (Albers & Sonsalla, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…It was shown that METH increases the ROS production via various pathways [129, 130] including the inhibition of mitochondrial functions [131] and the stimulation of the NADPH oxidase (NOX) activity [132]. METH-induced ROS production is implicated in METH effects on neuronal degeneration [133, 134], toxicity in various cell types [135, 136], behavioral hyperactivity [137, 138], and hyperthermia [139, 140]. Notably, ROS-reducing agents including ROS scavengers and NOX inhibitors attenuate those effects of METH.…”
Section: Sig-1r-related Molecular Mechanisms and The Actions Of Cocaimentioning
confidence: 99%